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Abstract 
Many biomolecules including proteolytic enzymes known as matrix metalloproteinases 
(MMPs) are released when a material, such as a microdialysis probe, is implanted in a living 
organism.  The MMPs cleave structural protein components of the extracellular matrix and play 
an important role in biological functions such as wound healing.1-3  Many enzymatic substrates 
for MMPs have fluorescent product mimics, and the mimics can be used as agents to monitor 
biochemical processes.1 
 In this study, microdialysis, a minimally invasive sampling technique, was combined 
with fluorescence imaging to determine the possibility of monitoring microdialysis in real-time, 
and thus provide a method that could ultimately lead to the ability to monitor localized MMPs..  
In vitro studies were conducted with fluorescent dyes IR-820 and Rhodamine B, producing 
promising results that illustrate combining microdialysis and fluorescence imaging is quite 
feasible.  The IR-820 was unpredictable during in vitro studies; therefore, it was not used in vivo, 
and Rhodamine B was selected to develop and optimize the combined method due to its stability.  
Microdialysis probes embedded in agarose phantoms, perfused with Rhodamine B, and imaged 
via a fluorescent imaging system clearly revealed a diffusion profile developing with time.  
Increased intensity surrounding the probe during infusion was also visible. 
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1. Objectives 
The objective of this project is to determine the feasibility of combining in vivo 
fluorescence imaging with microdialysis sampling.  Specifications to consider for this coupled 
method include the sensitivity of the imaging method, the distance the dye can be imaged from 
the microdialysis probe during long-term infusion, and the ability of the instrument to monitor a 
time-course during infusion.  These conditions are affected by extraction properties of 
microdialysis sampling, such as analyte diffusion coefficients and kinetic rate constants.  
However, these parameters are poorly characterized in the tissue space.4  In vivo fluorescence 
imaging of diffusion profiles resulting from infused near-infrared (NIR) dyes through an 
implanted microdialysis probe provides a real-time and uniquely innovative approach toward 
visually observing mass transport processes affecting microdialysis sampling extraction 
efficiency.  Interpreting in vivo data from the combined methods of fluorescence imaging and 
microdialysis sampling first requires a thorough understanding of the process in vitro. 
In vitro models are often used to model biological process.  Phantoms are imaging 
models of known geometric dimensions and material construction.  They are most often used in 
research of medical imaging to provide a tissue-like material for in vitro studies.5  Microdialysis 
probes embedded in phantoms, perfused with fluorescent dye, and imaged can reveal whether or 
not a diffusion profile can be detected. 
A long term goal of this project is to determine if localized matrix metalloproteinases 
(MMPs) can be measured via this coupled method of live imaging of microdialysis.  When a 
material, such as a microdialysis probe, is implanted in a living organism, a foreign body 
reaction (FBR) occurs, leading to the release of many biomolecules including proteolytic 
enzymes known as MMPs, which cleave structural protein components of the extracellular 
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matrix and play an important role in pathogenic and biological functions such as wound 
healing.1-3  Many enzymatic substrates for MMPs have fluorescent product mimics, such as 
elastase, which displays substrate specificity similar to MMP-12, and can therefore be used as 
agents to monitor biochemical processes.1 
2. Background 
2.1 Microdialysis Sampling 
In vivo microdialysis sampling is a widely-used, minimally-invasive sampling technique.  
A perfusion fluid is infused at μL/min flow rates through the lumen of a hollow-fiber dialysis 
membrane, allowing delivery of a solution and collection of unbound solutes from extracellular 
fluid (Figure 1).6,7  The resulting dialysate represents the biochemical functions of molecules 
surrounding the dialysis probe.  Parameters influencing extraction properties such as diffusion 
coefficients and kinetic rate constants are difficult to know a priori.  Few methods allow 
researchers to peek into what is happening within a biological system; one of these methods is in 
vivo fluorescence imaging. 
 
Figure 1. Diffusion across a microdialysis probe. 
Relative recovery relates the concentration of a substance in the extracellular fluid and 
the concentration of the same substance in the dialysate; it is the concentration of the substance 
in the dialysate divided by its concentration in the extracellular fluid shown in Equation 1 
𝑅 =  
𝐶𝑖𝑛−𝐶𝑑𝑖𝑎𝑙
𝐶𝑖𝑛
     Equation 1 
10 mm 
o.d. 500 μm 
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where Cin and Cdial are the perfusate and dialysate concentrations of a compound, respectively.
8  
There are several variables that influence the relative recovery of a system.  The relative 
recovery is inversely proportional to the flow rate, with commonly used flow rates ranging from 
0.1 μL/min to 5 μL/min.  Recovery will increase linearly with an increase in membrane surface 
area when a high concentration gradient is maintained between extracellular fluid and the 
dialysate.  At higher temperatures diffusion increases, thus recovery increases at higher 
temperatures.  Other variables that affect relative recovery include membrane and tubing 
material and geometry and perfusate composition.8 
 During microdialysis sampling, there are three regions of mass flux: the dialysate, 
the membrane, and the bulk solution (in vitro) or the tissue (in vivo). The following equations 
describe the flux occurring in each region.9  For simplification, Cartesian coordinates are used 
(Figure 2), noting the true model requires the use of cylindrical coordinates. 
 
𝑗𝑑𝑖𝑎𝑙𝑦𝑠𝑎𝑡𝑒 =  −𝐷𝑑𝑖𝑎𝑙𝑦𝑠𝑎𝑡𝑒
𝑑𝑐
𝑑𝑥
      (1)     𝑗𝑚𝑒𝑚𝑏𝑟𝑎𝑛𝑒 =  −𝐷𝑚𝑒𝑚𝑏𝑟𝑎𝑛𝑒
𝑑𝑐
𝑑𝑥
      (2) 
𝑗𝑏𝑢𝑙𝑘 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 =  −𝐷𝑏𝑢𝑙𝑘 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛
𝑑𝑐
𝑑𝑥
      (3)       𝑗𝑡𝑖𝑠𝑠𝑢𝑒 =  −𝐷𝑡𝑖𝑠𝑠𝑢𝑒
𝑑𝑐
𝑑𝑥
− 𝑘[𝑐]     (4) 
 
In these equations, j is the flux, D is the diffusion coefficient, c is the concentration of the solute, 
and x is the position within the system. For tissue, the flux must take kinetic removal processes 
into account.9  The flux in tissue is described by Equation 4, where k is a lumped kinetic removal 
term that includes removal via capillary permeability and metabolism. 
 
 
Figure 2.  The dialysate, dialysis probe 
membrane and tissue/bulk solution. 
x0 to xir : dialysate.   xir to xor: probe 
membrane. 
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2.2 Coupling Microdialysis Sampling with Fluorescence Imaging 
During fluorescence imaging, a fluorescent dye is subject to a certain wavelength of light 
that excites electrons.  Electrons then relax, emitting a photon at a wavelength related to the 
energy difference between the excited and relaxed states.10  Through imaging the fluorescence in 
vivo, the “visualization of biology in its intact and native physiological state” is possible. 10, 11 
By utilizing in vivo fluorescence imaging of microdialysis, the real-time occurrence of 
the diffusion process between introducing the perfusion fluid to the system and collecting the 
dialysate can be viewed by creating appropriate mathematical models of diffusion and kinetics 
for microdialysis sampling and correlating experimental microdialysis data in vitro. 
 The imaging system used in this study is an IVIS Lumina XR.  The IVIS system is 
equipped with a charge coupled device (CCD) that has a spatial resolution of 1024x1024 
pixels.12  The CCD, a photosensitive detector, measures the electrical charge of each pixel in an 
image and assigns a numerical value to that charge called counts.  The electrical charge of each 
pixel is directly proportional to the amount of light it was exposed to, and the CCD camera 
saturation is about 60,000 counts. 
 Several parameters of the IVIS imaging system affecting sensitivity were varied during 
optimization of the process.  These parameters include the binning, the f/stop, and the exposure 
time.  With increased binning, the data for adjacent pixels are combined into bigger and fewer 
pixels.13  This allows better signal-to-noise ratio and improves readout speeds.  In the IVIS there 
are binning settings of 1, 2, and 3 (small, medium, high).12  A binning of 1 has an area of 4x4 
pixels, a binning of 2 has an area of 2x2 pixels which gives a signal that is four times that of the 
1 binning and is double the spatial size.  At a binning of 4 there is a single megapixel with 
sixteen times the signal and four times the spatial size.  As binning increases, the spatial 
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resolution decreases.  However, this can be overcome by decreasing the field of view (FOV, 
increasing magnification) as the binning is increased, because CCD pixels are smaller at higher 
levels of magnification. 
The IVIS system has f/stop settings ranging from 2 to 16.12  The f/stop affects the amount 
of light that is allowed into the camera with lower f/stops allowing more light into the camera.  
Lower f/stops decrease the depth of the field imaged, but contain increased sensitivity.  Exposure 
time also affects sensitivity.12  Increased exposure time allows increased sensitivity, but needs to 
be low enough that the image doesn’t become saturated and high enough to avoid background 
“noise”. 
Radiant efficiency is the suggested measurement for fluorescence, and it is defined as “a 
fluorescence emission radiance per incident excitation power.”12  The minimum detectable 
radiance, the photon emission from the subject, for the IVIS is 100 photons/s/sr/cm2.12, 14 
 
3. Materials and Methods 
3.1 Chemicals 
Rhodamine B, Dextran-500, and Tris(hydroxymethyl)aminomethane (TRIS base),  
Ethlyenediaminetetraacetic acid (EDTA) were purchased from Sigma-Aldrich (St. Louis, MO).  
Solutions used in this work were Ringer’s solution (147 mM NaCl, 4.6 mM KCl, 2.3 mM CaCl2, 
pH 7.4); Ringer’s and 6% Dextran-500 (pH 7.4); or Ringer’s, 6% Dextran-500, and 0.1% (w/v) 
Bovine Serum Albumin, BSA (Rockland Inc., Gilbertsville, PA), pH 7.4.  Agar PCR Plus (EMD 
Millipore, (San Diego, CA) was used to  prepare 2% agar phantoms in a 1:50 diluted Tris-
acetate-Ethylenediaminetetraacetic acid (TAE) buffer consisting of 2 M (TRIS base), 7.15 mL 
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acetic acid, 12.5 mL (EDTA) (0.5 M, pH 8.0), and 62.5 mL HPLC-grade water (Fisher 
Scientific, Waltham, MA).  All other chemicals were reagent grade or better. 
 
3.2 Microdialysis Sampling 
CMA-20 microdialysis probes (Harvard Apparatus, (Holliston, MA)) with 
polyethersulfone (PES) membranes (100 kDa molecular weight cut-off (MWCO) and 10 mm 
length) were used for all experiments.  A BASi microdialysis syringe pump, controller, and 
syringes (Bioanalytical Systems Inc., West Lafayette, IN, USA) were used to perfuse fluids 
through the microdialysis probes.  For in vitro relative recovery experiments, probes were 
immersed into continuously stirred Rhodamine B solutions (20 μM and 200 µM) in Ringer’s 
heated to 35 °C and perfused with a solution of Ringer’s, 6% Dextran-500, and 0.1% (w/v) BSA 
at 1 µL/min. Samples were collected every hour for five hours.  Collected dialysate samples (30 
μL to 60 μL) were measured at 556 nm (NanoDrop 2000c, Thermo Scientific, Pittsburgh, 
Pennsylvania) and concentrations were determined by comparing their absorbance vs. standard 
curves. 
 
3.3 In vitro Imaging 
 To obtain fluorescence images of dye’s diffusion profile, an IVIS Lumina XR in vivo 
imaging system (Caliper Life Sciences, Hopkinton, MA) via Living Image Software 
(PerkinElmer, Waltham, MA) was used with the following parameters: 5 sec exposure time, 
small binning, f/stop 2, field of view C, and 535/Cy5.5 excitation/emission filters.  Microdialysis 
probes were embedded in 2% agar phantoms and connected to a CMA pump (CMA, A Harvard 
Apparatus Company, Holliston, MA) attached to a 12 V battery and perfused at 1 µL/min with 
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either 20 μM or 200 µM Rhodamine B in a solution of Ringer’s, 6% Dextran-500, and 0.1% 
(w/v) BSA, pH 7.4.  Images were obtained at five minute intervals for three hours. 
 
3.4 In Vivo Imaging 
Background fluorescence images of a naïve male Sprague-Dawley rat (250 g) were 
obtained at various imaging settings (including the same imaging conditions used for the agar 
gels as previously described) using the appropriate excitation and emission wavelength filters for 
Rhodamine B (535 nm, Cy5.5, respectively).  Rats were anesthetized in an isoflurane induction 
chamber and imaged in the Lumina XR while maintaining 2.5% isoflurane/ 0.8 L/min oxygen. 
 
4. Results 
 Two dyes were used during the experiments for this study: IR-820 and Rhodamine B.  
IR-820 is a near-infrared (NIR) dye with a molecular weight of 849.47g/mol, and its excitation 
and emission wavelengths are 710 nm and 820 nm, respectively.15, 16  Rhodamine B fluoresces in 
the visible light spectrum.  Rhodamine B has a molecular weight of 479.01 g/mol, and the 
excitation and emission wavelengths are 554 nm and 627 nm, respectively.17 
 
4.1 IR-820 
Fluorescent dye IR-820 was originally chosen to aid in optimization and method 
development of combining microdialysis sampling with fluorescent imaging.  IR-820 was chosen 
in part due to the fact that the NIR excitation and emission wavelengths for the dye are suitable 
for in vivo work.  However, due to its unpredictable and unexpected behavior witnessed in vitro, 
it was not investigated in vivo during this study.  In vitro IR-820 studies included well plate and 
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phantom experiments.  Figure 3 shows IR-820 in a well plate.  This image was taken using the 
fluorescent imaging settings on the IVIS Lumina XR system.  The IR-820 was dissolved in 
water, Ringer’s, Ringer’s plus Dextran, and Ringer’s plus Dextran and BSA to compare its 
behavior in various solutions.  Rows A, C, E, and G contain these solutions, respectively.  Wells 
in column one were filled with a concentration of 235 μM and serial diluted down each row.  
The strongest fluorescent signal is expected to be in the first column with it weakening as it 
continues down the row.  This is not the case with the IR-820, as seen in the figure below, as it 
tends to start with a weak or no fluorescent signal, then gradually develops a stronger signal, and 
finally weakens again. 
 The IR-820 only strongly fluoresced in water and in Ringer’s, 6% Dextran, and 0.1% 
(w/v) BSA.  There is a very small amount of fluorescence in wells E2 thorugh E6 in a solution of 
Ringer’s and 6% Dextran.  These wells correlate with with the stronger fluorescent signals in 
rows A and G which could mean this is an actual fluorescent signal and not simply backgound.  
Row H contains a solution of Ringer’s, 6% Dextran, and 0.1% (w/v) BSA.  The signal in this 
row is thought to be background, and since it is a stronger singal than that in Row E, it could be 
assumed that the color in Row E is background and not an actual fluorescent signal.  As shown 
in row C, the IR-820 did not fluoresce at all in only Ringer’s solution.  Note:  Rows B, D, F, and 
H contain water, Ringer’s, Ringer’s and 6% Dextran, and Ringer’s, 6% Dextran, and 0.1% (w/v) 
BSA, respectively, with no dye.  The dye fluoresces much more strongly in Row G, which 
contains BSA, and Row H shows fluorescence even though there is no dye in the wells.  This 
indicates that BSA may be interefereing with the fluorescent signal of the dye.  IR-820 seems to 
increase in fluorescence intensity with decreasing dye concentration until it reaches a certain 
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concentration, then the fluorescent intensity decreases with decreasing concenetration.  The dye 
is also not consistent in the way it behaves in the varying solutions shown. 
 
Figure 3.  Well plate containing serial diluted IR-820 dye in various solutions.  Settings used:  medium binning, 
f/stop 2, and 30 s exposure time. 
 
Instrument Optimization 
 To determine the optimal imaging settings, parameters of the imaging system were varied 
to provide an image with the best spatial resolution.  A field of view (FOV) of 12.5 cm (FOV D) 
was used for all plate images, and a FOV of 10 cm (FOV C) was used for phantoms images. 
 Table 1 displays the methods that were initially used to image IR-820 as it was being 
perfused through agarose gels.  Images were taken of the phantoms every 15 minutes for one 
hour at each of the methods in the table.  Method 002 was no longer applied to IR-820 after this 
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experiment as there was not any fluorescence detected after 30 minutes of perfusion.  Figures 4 
and 5 display images for Methods 001 and 005 for IR-820. 
 
Table 1.  Methods used to determine imaging settings for IR-820. 
Method Exposure Time (s) Binning f/stop 
Excitation/Emission 
Filters 
001 0.5 Medium 2 745/ICG 
002 1 Small 2 745/ICG 
005 60 Small 16 745/ICG 
 
 
 
Figure 4.  IR-820 dissolved in a solution of Ringer’s, 6% Dextran, and 0.1% (w/v) BSA, perfused at 1 μL/min, 0.5 
second exposure time, medium binning, f/stop 2, and excitation/emission filters of 745/ICG. 
Time 0 min Time 15 min Time 30 min 
Time 45 min Time 60 min 
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Figure 5.  IR-820 dissolved in a solution of Ringer’s, 6% Dextran, and 0.1% (w/v) BSA, perfused at 1 μL/min, 60 
second exposure time, small binning, f/stop 16, and excitation/emission filters of 745/ICG. 
 
 As you can see in Figure 4, the IR-820 is unpredictable.  The fluorescence intensity 
should increase with each 15 minute interval; however, there is no fluorescence detected after 60 
minutes of perfusion, even though fluorescence is clearly seen after 45 minutes of perfusion.  In 
Figure 5, an increase in fluorescence intensity is seen from one image to the next.  The dye was 
expected to spread out from the probe, developing a diffusion profile, however the dye appears 
to remain close to the probe. 
 
 
 
Time 0 min 
Time 60 min Time 45 min 
Time 30 min Time 15 min 
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4.3 Rhodamine B 
 Because IR-820 proved unpredictable, fluorescent dye Rhodamine B was chosen for its 
stability to aid in the development and optimization of this combined method. 
Instrument Optimization 
 Table 2 displays the imaging settings examined for Rhodamine B.  Methods 001, 002, 
and 005 are the same settings used with IR-820, but the excitation and emission filters were 
changed to suite the excitation and emission characteristics of Rhodamine B. 
Table 2.  Methods used to determine imaging settings for Rhodamine B. 
Method Exposure Time (s) Binning f/stop 
Excitation/Emission 
Filters 
001 0.5 Medium 2 535/Cy5.5 
002 1 Small 2 535/Cy5.5 
003 1 Medium 2 535/Cy5.5 
004 1 Small 16 535/Cy5.5 
005 60 Small 16 535/Cy5.5 
006 1 Small 4 535/Cy5.5 
007 1 Small 8 535/Cy5.5 
 
First, the same methods that were applied to IR-820 were applied to Rhodamine B while 
perfusing it through microdialysis sampling probes implanted in agarose gels.  Background 
images (time at t=0) taken for Methods 001 and 005 returned too much background “noise” 
meaning the image showed there was fluorescence when there wasn’t anything fluorescent in the 
frame suggesting background scatter or unexpected autofluorescence.  Some background 
fluorescence can be removed by manually scaling the radiant efficiency, but I have found that 
removing extensive amounts of background “noise” can remove data as well. 
The minimum of the scale is determined by the amount of background present in the 
image at time t=0, or the background image.  The background image is manually scaled to 
subtract any “noise” that may be visible in the image.  After most, if not all, of the background is 
removed from the background image, the minimum on the scale for the background image is 
16 
 
used as the absolute minimum for the remaining images.  The minimum may be raised slightly 
depending on whether or not there seems to be excessive fluorescence around the probe (or if a 
previously used probe is used again and it still has some dye in it).  During the first experiment 
conducted, new probes were used.  The minimum determined during this experiment was the 
basis for the minimum on following experiments.  Figures 6-8 show the steps for this method. 
 
Figure 6.  Agar phantoms at time t=0 minutes.  Perfusion has not started, but there is background “noise 
surrounding the frame of the image.  Note the minimum on the scale is 2.3x106 [(p/sec/cm2/sr)/(μW/cm2)]. 
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Figure 7.  Agar phantoms at time t=0 minutes.  Perfusion has not started.  There is less background “noise” than in 
Figure 6.  This is because the minimum on the scale was increased to remove background.  Note the minimum on 
the scale is 3x106 [(p/sec/cm2/sr)/(μW/cm2)]. 
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Figure 8.  Agar phantoms at time t=0 minutes.  Perfusion has not started.  Background “noise” has been removed 
because the minimum on the scale was increased until there wasn’t any background in the image.  Note the 
minimum on the scale is 3.95x106 [(p/sec/cm2/sr)/(μW/cm2)]. 
 
The remaining methods were examined using a well plate with Rhodamine B in water, 
Ringer’s plus Dextran, and Ringer’s plus Dextran and BSA in rows A, C, and E, respectively.  
Following are images of different methods and a short discussion of each. 
Method 002 
Figures 9, 10, and 11 show Method 002 applied to Rhodamine B at an exposure time of 1 
second, 5 seconds, and 30 seconds, respectively.  Method 2 at an exposure of 5 seconds was 
determined to be the best option for Method 002.  There is less background “noise” at an 
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exposure of 5 seconds than at an exposure of 1 second.  An exposure of 30 seconds causes the 
image to become over-exposed. 
 
Figure 9.  Well plate imaged with Rhodamine B in water, Ringer’s and 6% Dextran, and Ringer’s, 6% Dextran 500, 
and 0.1% BSA in rows A, C, and E respectively with an exposure time of 1 second and an f/stop of 2.  Starting 
solution in column 1 is 200 μM Rhodamine B.  The solution was serial diluted down each row. 
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Figure 10.  Well plate imaged with Rhodamine B in water, Ringer’s and 6% Dextran, and Ringer’s, 6% Dextran 
500, and 0.1% BSA in rows A, C, and E respectively with an exposure time of 5 seconds and an f/stop of 2.  Starting 
solution in column 1 is 200 μM Rhodamine B.  The solution was serial diluted down each row. 
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Figure 11.  Well plate imaged with Rhodamine B in water, Ringer’s and 6% Dextran, and Ringer’s, 6% Dextran 
500, and 0.1% BSA in rows A, C, and E respectively with an exposure time of 30 seconds and an f/stop of 2. 
Starting solution in column 1 is 200 μM Rhodamine B.  The solution was serial diluted down each row. 
 
 Method 003 is the same as Method 002 except with a medium binning instead of a small 
binning.  The medium binning provided the same amount of fluorescent information, but the 
small binning provided an image with better spatial resolution at the FOV used. 
Method 004 
 Figure 12 shows Rhodamine B imaged using Method 004.  An f/stop of 16 was used for 
Method 004 as opposed to the f/stop of 2 that was used in Method 002.  The f/stop changes the 
amount of light that enters the camera.  Smaller f/stops allow more light to enter the cameral lens 
than larger f/stops.  The larger f/stop decreased the amount of “noise” in the image, but now 
there isn’t any fluoresence showing in column 7 and very little in column 6.  The smaller f/stop 
clearly showed fluoresence in these columns. 
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Figure 12.  Well plate imaged with Rhodamine B in water, Ringer’s and 6% Dextran, and Ringer’s, 6% Dextran 
500, and 0.1% BSA in rows A, C, and E respectively with an exposure time of 1 second and an f/stop of 16.  
Starting solution in column 1 is 200 μM Rhodamine B.  The solution was serial diluted down each row. 
 
Method 006 
 Method 006 has an f/stop of 4.  Figures 13, 14, and 15 were taken using the settings of 
Method 006 at exposures of 1 second, 5 seconds, and 30 seconds, respectively.  The 5 second 
and 30 second exposures both show fluorescence in the 7th column which is consistent with the 
settings of Method 002.  At an exposure of only 1 second however, there is little fluorescence in 
this column. 
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Figure 13.  Well plate imaged with Rhodamine B in water, Ringer’s and 6% Dextran, and Ringer’s, 6% Dextran 
500, and 0.1% BSA in rows A, C, and E respectively with an exposure time of 1 second and an f/stop of 4.  Starting 
solution in column 1 is 200 μM Rhodamine B.  The solution was serial diluted down each row. 
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Figure 14.  Well plate imaged with Rhodamine B in water, Ringer’s and 6% Dextran, and Ringer’s, 6% Dextran 
500, and 0.1% BSA in rows A, C, and E respectively with an exposure time of 5 seconds and an f/stop of 4.  Starting 
solution in column 1 is 200 μM Rhodamine B.  The solution was serial diluted down each row. 
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Figure 15.  Well plate imaged with Rhodamine B in water, Ringer’s and 6% Dextran, and Ringer’s, 6% Dextran 
500, and 0.1% BSA in rows A, C, and E respectively with an exposure time of 30 seconds and an f/stop of 4.  
Starting solution in column 1 is 200 μM Rhodamine B.  The solution was serial diluted down each row. 
 
Method 007 
 Figure 16 displays Rhodamine B imaged under the settings of Method 7.  The f/stop used 
in this method (f/stop 8) is less than that of Method 004 (f/stop 16), but greater than that of 
Method 006 (f/stop 4).  The image contains quite a bit of background. 
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Figure 16.  Well plate imaged with Rhodamine B in water, Ringer’s and 6% Dextran, and Ringer’s, 6% Dextran 
500, and 0.1% BSA in rows A, C, and E respectively with an exposure time of 1 second and an f/stop of 8.  Starting 
solution in column 1 is 200 μM Rhodamine B.  The solution was serial diluted down each row. 
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fluorescence images.  The exposure times presented for Methods 002 and 006 suggest that an 
optimal exposure time is about 5 seconds.  In Method 002 the 5 second exposure time reduced 
background “noise”, but didn’t seem to overexpose the image.  In Method 006 the 5 second 
exposure provided more data than the 1 second exposure time.  The images taken at a 5 second 
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2, and with Method 006, f/stop 4, appeared to give about the same fluorescent intensity.  Thus 
the settings for Rhodamine B imaging were based off Method 002 at an exposure time of 5 
seconds. 
Microdialysis Sampling 
Relative Recovery 
 Because microdialysis involves a constant flow rate, concentration equilibrium is 
impossible to establish, thus relative recovery data is gathered to relate information about 
concentrations in the extracellular fluid.  In vitro relative recovery experiments were performed 
to determine the relative recovery of Rhodamine B.  The relative recovery of Rhodamine B is 
displayed in Table 3.  The average relative recovery for 312.7 μM and 31.3 μM is 82.4%±0.58 
and 64.8%±3.9, respectively. 
Table 3. Relative recovery of Rhodamine B.  Microdialysis probes were submersed in heated (35°C) 312.7 μM and 
31.3 μM Rhodamine B in Ringer’s solution and perfused with a solution of Ringer’s, 6% Dextran, and 0.1% BSA.  
Initial Concentration (µM) Sample Absorbance Concentration (µM) % Recovery 
312.7 
1 1.59 255.36 81.66 
2 1.61 257.56 82.37 
3 1.61 258.15 82.56 
4 1.62 259.76 83.07 
31.3 
1 0.14 19.99 63.85 
2 0.15 20.48 65.43 
3 0.15 20.34 64.98 
4 0.13 18.58 59.35 
5 0.16 21.96 70.15 
 
In Vitro Microdialysis 
 A diffusion profile of Rhodamine B can be clearly detected via fluorescence imaging of 
the microdialysis process.  Figure 17 shows the development of a diffusion profile surrounding a 
probe in agar as a function of time.  Images were taken every 5 minutes for 3 hours.  The top and 
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bottom phantom in each image is perfused with 20 μM and 200 μM Rhodamine, respectively.  
For the 200 µM infusion, the profile is clearly visible after only 10 minutes of microdialysis 
sampling, and the 20 µM concentration is not visible until around 40 minutes.  The 20 μM was 
tested by itself in the IVIS system, and fluorescence is also visible starting at about 10 minutes, 
but it doesn’t develop a profile similar to the 200 μM at 10 minutes until about 40 minutes of 
perfusion.  See Figure 18.  The IVIS machine automatically scales each image, but the images 
can be manually scaled.  Images that were taken towards the beginning of the process can be 
scaled in such a way that the lower concentration becomes visible.  Doing this however, causes a 
lot of background “noise” to appear around the phantom with the higher concentration (displayed 
in Figure 19), thus the images were scaled to reduce background around the phantom perfused 
with the 200 μM Rhodamine B. 
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Figure 17.  Rhodamine B microdialysis diffusion profile over time in agar phantoms.  The top and bottom phantom 
in each image is perfused with 20 µM and 200 µM, respectively.  
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t=40 t=60 t=80 t=100
t=120 t=140 t=160 t=180
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Figure 18.  20 μM Rhodamine B microdialysis diffusion profile over time in agar phantoms.  
t=0 min t=5 t=10 t=20
t=40 t=60 t=80 t=100
t=120 t=140 t=160 t=180
31 
 
 
Figure 19.  Scale was changed to bring out the profile of the lower concentration at an earlier time.  You can see the 
profile starting at about 20 minutes, but it creates a lot of “noise”.  This is evident by the fluorescent signals showing 
up far away from where the dye could be. 
 
Starting at time t = 40 minutes, there is some fluorescence on the phantom, but too far 
from the probe to be dye.  This is background “noise” that cannot be completely removed 
without affecting the diffusion profile around the probe.  To obtain data when this “noise” is 
present, regions of interest (ROIs) can be selected.  ROIs provide fluorescence data (radiant 
efficiency or counts) within the region selected.  ROIs can be selected automatically or manually.  
By manually selecting a ROI, the background “noise” on the phantom can be ignored and the 
fluorescence data around the probe can be reported. 
t=0 min t=5 t=10 t=20
t=40 t=60 t=80 t=100
t=120 t=140 t=160 t=180
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Reproducibility of In Vitro Studies 
 The in vitro studies were repeated to determine the reproducibility of their results.  As 
shown in the following figures, the process is very reproducible; the experiments all returned 
similar images. 
 
Figure 20.  Run 1.  Time course infusion of Rhodamine B for 3 hours. 
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Figure 21.  Run 2.  Time course infusion of Rhodamine B for 3 hours. 
 
Figure 22.  Run 3.  Time course infusion of Rhodamine B for 3 hours. 
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Figure 23.  Run 4.  Time course infusion of Rhodamine B for 3 hours. 
 
Figure 24.  Run 5.  Time course infusion of Rhodamine B for 3 hours. 
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Figure 25.  Run 6.  Time course infusion of Rhodamine B for 3 hours. 
 
In Vivo Studies 
 A naïve rat was imaged under the same imaging settings for the Rhodamine B in vitro 
studies.  As Figure 26 reveals, there is a considerable amount of natural fluorescence from the 
animal at the appropriate wavelengths for imaging the infusion of Rhodamine B.  This “auto-
fluorescence” of tissue and biosubstrates creates a significant problem in rendering background 
subtraction of fluorescence images of the infusion process impossible and in vivo imaging at 
wavelengths necessary for Rhodamine B impossible. 
 An in vivo imaging protocol by Perkin Elmer stated that the rat’s hair can block, absorb, 
and scatter light due to a high chlorophyll diet.18  This problem also occurs in the NIR range of 
light because chlorophyll tends to “auto-fluoresce” at around 700 nm.  Recommendations made 
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to adjust for this include shaving the area of the rat to be imaged and changing the rat’s diet to 
one consisting of a low chlorophyll concentration about two weeks before imaging. 
 
Figure 26.  Naïve rat imaged with the following settings: excitation/emission filters – 535/Cy5.5, small binning, 
f/stop 2, and 1 s exposure time. 
5. Conclusion 
 The IR-820 dye is unpredictable during in vitro studies.  It is recommended that more the 
behavior of IR-820 be studied further before using it in conjunction with the method proposed in 
this paper.  It is possible that dissolving IR-820 in an organic solvent will correct the problems 
we had, however that was not tested here. 
 In vitro infusion of Rhodamine B into agarose gels clearly reveals the diffusion of dye 
throughout the gel and an increase in fluorescence intensity surrounding the probe over time.  
Relative recovery of Rhodamine B shows increased recovery over the course of the experiment.  
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These findings are foundational for future in vitro work and mathematical modeling, as well as 
being a springboard for in vivo experiments.  These studies strongly suggest the possibility of 
combining in vivo microdialysis sampling with in vivo fluorescence imaging for different 
biomedical related research. 
 Future goals should include using a near-infrared (NIR) dye that is more suitable for in 
vivo work and monitoring the diffusion profile of elastase.  Modeling for the new NIR dye in 
vitro and in vivo diffusion profiles should be developed by fluorescence imaging of the dye in 
microdialysis via a live imaging instrument.  The same imaging technique used for Rhodamine B 
can be applied to the NIR dye along with the appropriate excitation/emission filters.  Using an 
iterative approach, the dye should be infused at varying concentrations in agarose gels via 
microdialysis to determine a concentration that is sufficient to provide a signal in the instrument.  
The temporal resolution of the instrument, 0.5 s, can be optimized as needed to obtain 
appropriate diffusion profiles.  It is suggested that ROIs be determined for the diffusion profiles 
of the gels, and an in vitro standard curve produced.  An in vitro study of elastase can then be 
conducted by applying the mentioned techniques for the NIR dye studies using phantoms with 
porcine elastase (a mimic for MMP-12). 
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